Who is to say Healthcare Partners could not have done a better job?
Fair enough ... seems at this stage difficult to imagine anybody could have done a worse job. We probably will never know unless ... they wait another couple of days and make another offer just shy of $4?
----
"Prediction is very difficult, especially about the future" (Niels Bohr)
Down again , not the flavour of the week, big regigging of the financials having to take place with ABA before the market can settle on a value here imo!
Suggest you read Percy's last post as it is very relevant.
ALSO
(1) NPAT includes profit on sale of subsidiary-2.1m.For comparison purposes you need to exclude this & adjusted NPAT is $10.7m,down 4%
(2) 4.2m new shares were issued to fund its purchases of new businesses.Very importantly EPS has fallen 20% from 51.8 to 41.7
(3)This puts the PE on 21
(4)In addition to the share issue it received 17m from the sale of its subsidiary-cash on hand at year end was only $7-where is future funding coming from?
(5) Goodwill in BS stands at $227m.It has paid roughly $1m goodwill per business purchased.Each business contributes approx $47,000 npat per annum
so it will take about 20yrs profits to cover the goodwill.
(6) In the last yr it paid $38m in goodwill for 19 businesses.
(7) ROE was 7.7%
It really needs to be achieving a much better profit for each practice.The worry could come with goodwill writedowns for non performing businesses.Goodwill in
the books exceeds Equity.
Just my thoughts.
My post from August.. a big problem now is $220m in goodwill sitting in the books with write-offs coming.
NTA/share of -$4.08. Yes MINUS!
Basically they have been paying far too much for the businesses.I wonder if it can survive?
Wowee those guys at Forsyth picked it well yet again... similar to EVO (right before it fell off a cliff), on 10th October Forsyth (when the share price was $8.20) sent out a note to remove Abano Healthcare from their 'conviction list', although they mentioned they were still positive on the stock and the same day released a report with a target price of $10.25.
Just under 6 months later the share price is $3.90 (and they, on 27th march 2019, now have a target price of $5.75)
Bookmarks